Direction Change Ahead, What to Expect - Research & Analysis on Achillion Pharmaceuticals, Inc. and Vertex Pharmaceuticals Incorporated

Tue Nov 13, 2012 9:00am EST

* Reuters is not responsible for the content in this press release.

  JAKARTA, INDONESIA, Nov 13 (Marketwire) -- 
Moments ago, introduced new coverage of Achillion
Pharmaceuticals, Inc. (NASDAQ: ACHN) and Vertex Pharmaceuticals
Incorporated (NASDAQ: VRTX). Full outlook, analysis and consensus opinion
is available to readers via the links

    The consistent delivery of accurate analyses relies solely on two
factors, namely: market awareness and industry insight. Recent market
drivers include grim European forecasts with Germany's growth prospects
signaling potential trouble ahead, headlines of "fiscal cliff" concerns
with potential friction between Republicans and Democrats regarding
upcoming expiration of tax cuts and recent effects of Hurricane Sandy
still affecting major areas. When it comes to discovering the right edge
at the right time, all these factors play into effect. For a deeper
understanding of the mechanics behind these events and how it can affect
your portfolio, please refer to our email newsletter delivered to your

    Traders Insight is releasing new coverage on Achillion Pharmaceuticals,
Inc. for its current position within the consumer durables sector.
Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on
the discovery, development and commercialization of treatments for
infectious diseases. The Company is engaged in the development of
antivirals for the treatment of chronic hepatitis C infection (HCV), and
the development of antibacterials for the treatment of resistant
bacterial infections. A copy of this report featuring Achillion
Pharmaceuticals, Inc. (NASDAQ: ACHN) is available at:

    Traders Insight has released research on Vertex Pharmaceuticals
Incorporated for its changing role within the consumer durables sector.
Vertex Pharmaceuticals Incorporated (Vertex) is in the business of
discovering, developing, manufacturing and commercializing small molecule
drugs for the treatment of serious diseases. To access the full research
report on Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) we welcome
investors to visit:

    About Traders Insight
 Find direction and insight with Our model of enabling open collaboration between
members is breaking new ground into the investment community. By tapping
into the resources of the community, we are crowd-sourcing our reach. As
a result - we have been able to identify some of the greatest moving
companies on the market today. The evidence is in the results, join today
and experience what you've been missing.



Cora S. Patton 

Copyright 2012, Marketwire, All rights reserved.